首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Acs chemical neuroscience

缩写:ACS CHEM NEUROSCI

ISSN:1948-7193

e-ISSN:1948-7193

IF/分区:3.9/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引4421
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Cassandra J Hatzipantelis,Lindsay P Cameron,Min Liu et al. Cassandra J Hatzipantelis et al.
Exogenously administered psychedelics produce both rapid and long-lasting effects on neuroplasticity and behavior, but it is currently unclear if endogenously produced psychedelics can elicit similar effects. There have been relatively few ...
Sho Oasa,Wai H Mak,Adam L Maddox et al. Sho Oasa et al.
Excessive consumption of alcohol (ethanol (EtOH)) can lead to alcohol use disorder (AUD). While AUD can be managed through behavioral interventions, there is a great need for pharmacological remedies for this condition. To date, only three ...
Christopher R Brown,James D Foster Christopher R Brown
Autism spectrum disorder (ASD) is a developmental disorder of the nervous system characterized by a deficiency in interpersonal communication skills, a pathologic tendency for repetitive behaviors, and highly restrictive interests. The spec...
Shenghao Qian,Caizhen Shi,Bingbing Wang et al. Shenghao Qian et al.
Spinal cord injury (SCI) is a severe neurological disorder that not only causes significant physical and psychological harm to patients but also imposes a substantial economic burden on families and society. Following SCI, a cascade of seco...
Ramya Tokala,Chi-Hyeon Yoo,Joseph W Downey et al. Ramya Tokala et al.
Ataxia-telangiectasia mutated (ATM) kinase plays a crucial role in DNA damage response and has emerged as a promising therapeutic target. AZD1390, an ATM kinase inhibitor developed by AstraZeneca, is currently in phase I clinical trials as ...
Sadia Jaman,Salsabil Fatima Tasmi,Imrul Shahriar et al. Sadia Jaman et al.
Alzheimer's disease affects over 10% of individuals above the age of 65, yet current treatments offer only limited and temporary relief. Acetylcholinesterase, a key enzyme in neurotransmitter breakdown, also contributes to disease progressi...
Zahra R Khan,Philip J Welsby,Izabela Stasik et al. Zahra R Khan et al.
Glioblastoma (GBM) is the most common malignant brain tumor in adults but with limited and poorly effective treatment protocols. Kinase inhibitors either as a mono- or as a combination therapy have considerable potential as novel treatments...
Marie Perrier,Desirée Loreth,Johannes Brand et al. Marie Perrier et al.
Ubiquitination influences a myriad of biological processes, such as the trafficking or degradation of ubiquitin-tagged target proteins. This posttranslational modification can be reversed by deubiquitinating enzymes (DUBs) that counterbalan...
Nasser Alotaiq,Samir Chtita,Doni Dermawan Nasser Alotaiq
Peripheral nerve injury (PNI) remains a significant clinical challenge, often leading to impaired nerve regeneration and chronic neuropathic pain. Can Si (Silk Fibroin), a key component of traditional Chinese medicine (TCM), has long been r...
Ephraim Ezeigbo,Kaitlyn Keith,Zachary L Ellis et al. Ephraim Ezeigbo et al.
Many neurodegenerative diseases, including Alzheimer's (AD), Parkinson's (PD), and Huntington's disease (HD), are associated with proteinaceous deposits in the brain comprising amyloid. The aggregation process leading to these deposits proc...